Re: Yahoo poster claims a reverse split coming....
|
4
|
Resverlogix Corp.
|
Nov 10, 2018 01:57PM
|
Re: Zenith Capital Corp. to Present on the Emerging Growth Conference on September 25, 2024
|
4
|
Zenith Epigenetics
|
Oct 15, 2024 12:11PM
|
RVX 297 publication news from rndtbl from IV
|
4
|
Resverlogix Corp.
|
Oct 03, 2017 08:47AM
|
Re: Cash burn and the cost of servicing the loan....
|
4
|
Resverlogix Corp.
|
Apr 16, 2018 12:42PM
|
Nature article on apabetalone and HIV, hope this wakes up the market
|
4
|
Resverlogix Corp.
|
Dec 12, 2017 07:49AM
|
Re: Amarin CEO interview - New class action lawsuit
|
4
|
Resverlogix Corp.
|
Nov 14, 2018 08:32PM
|
Re: What's going on with the Phase 2 ZEN-3694 mCRPC trial?
|
4
|
Zenith Epigenetics
|
Jul 26, 2019 10:50AM
|
Re: ZHCLF
|
4
|
Zenith Epigenetics
|
Jan 30, 2024 04:37PM
|
Re: Resverlogix Announces Extension of Maturity Date of Loan and Expression of Interest Regarding Strategic Transaction
|
4
|
Resverlogix Corp.
|
Aug 28, 2017 10:36AM
|
Re: MACE event rate
|
4
|
Resverlogix Corp.
|
Nov 04, 2018 10:46AM
|
Re: Zenith Epigenetics Announces Dosing of First Patient in Triple Negative Breast Cancer Trial with Pfizer
|
4
|
Zenith Epigenetics
|
Jun 27, 2019 10:43AM
|
Re: Reaching 250 MACE
|
4
|
Resverlogix Corp.
|
Apr 23, 2019 11:10AM
|
Re: Early Warning Report
|
4
|
Zenith Epigenetics
|
Nov 29, 2020 09:55AM
|
Re: We broke through the Resistance at $2.15
|
4
|
Resverlogix Corp.
|
Oct 05, 2016 02:53PM
|
Re: One week til the EAS Congress in Prague....April 2017 Fact Sheet PDF
|
4
|
Resverlogix Corp.
|
Apr 15, 2017 01:03PM
|
Re: Resverlogix’s Apabetalone Demonstrates a Medical First in Patients with Chronic Kidney Disease
|
4
|
Resverlogix Corp.
|
Apr 27, 2021 04:02PM
|
Re: BIO-Europe Presentation
|
4
|
Resverlogix Corp.
|
Mar 15, 2018 08:20AM
|
Re: Slide 27 - I would get rid of it....
|
4
|
Resverlogix Corp.
|
Sep 17, 2016 05:17PM
|
Re: Zenith Epigenetics did not respond to invitatations in this one
|
4
|
Zenith Epigenetics
|
May 31, 2021 01:14PM
|
Re: At least we're getting some intersting trading...
|
4
|
Resverlogix Corp.
|
Mar 09, 2017 10:03AM
|